A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
DermatomyositisMyositis
Interventions
BIOLOGICAL

Empasiprubart IV

Intravenous infusion with Empasiprubart IV

OTHER

Placebo IV

Intravenous infusion with Placebo IV

Trial Locations (28)

2025

Timofei Mosneaga Republican Clinical Hospital, Chisinau

12462

National and Kapodistrian University of Athens (NKUA) - University General Hospital Attikon, Athens

15707

Nova Reuma Domyslawska i Rusilowicz- Spolka Partnerska Lekarza Reumatologa i Fizjoterapeuty, Bialystok

16121

Andreas Syggros Hospital of Skin and Venereal Diseases - University Dermatology and Venereology, Athens

32610

University of Florida Health (UF) - Endocrinology - Medical Specialties - Medical Plaza, Gainesville

32713

Omega Research Debary, LLC, DeBary

33033

Homestead Associates in Research, Inc., Homestead

33063

Life Clinical Trials, Margate

33135

Advance Medical Research Center, Miami

33321

D and H Tamarac Research, LLC Center, Tamarac

33324

Integral Rheumatology and Immunology Specialists (IRIS), Plantation

41010

Hospital Quironsalud Infanta Luisa, Seville

45324

Wright State Physicians Health Center, Dayton

47012

Hospital Universitario Rio Hortega, Valladolid

56126

Azienda Ospedaliera Universitaria Pisana, Pisa

56429

General Hospital of Thessaloniki Papageorgiou, Thessaloniki

92056

Profound Research LLC, Oceanside

0102

V.Tsitlanadze Scientific Practical Reumatology Center, Tbilisi

0141

The First University Clinic of Tbilisi State Medical University, Tbilisi

0159

Institute of Clinical Cardiology, Ltd, Tbilisi

0167

Jerarsi Clinic, Tbilisi

0179

Mtskheta street Clinic, Tbilisi

0180

The First Medical Center, Tbilisi

00128

Fondazione Policlinico Universitario Campus Bio-Medico, Rome

MD2025

Institute of Cardiology, Chisinau

61-397

Prywatna Praktyka Lekarska Prof. UM dr Hab. Med. Pawel Hrycaj, Poznan

50-556

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw

08003

Parc de Salut Mar - Hospital del Mar, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

argenx

INDUSTRY

NCT06284954 - A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis | Biotech Hunter | Biotech Hunter